Login

I cannot remember my username

Our New Website Is Here!
As part of our merger with St. Paul Research, we’ve created a new website that will house all of our collective content under one roof, bringing you a higher level of research and service through our analysts’ combined insight, expertise, and perspective. Go to my.stpaulresearch.com to access our new site.

Technology Profits Confidential

The world of tech and biotechnology will provide endless opportunity for growth and wealth for investors who know where to look.

Technology Profits Confidential is your one-stop shop for the companies of tomorrow's technology... and how you can profit from them.

The Lights Went out All Over Texas

Ray Blanco
By Ray BlancoPosted February 19, 2021

Unusually cold winter weather knocked out Texas electricity production and left millions without heat just as they needed it most. It’s an example of how shortsightedness with respect to our power grid can leave us out in the cold. It’s yet another reason we need to be deploying new energy technology to help us have a more robust and reliable grid.

You Must Be A Subscriber To View This Content.

If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication(s) below and get access today!

Technology Profits Confidential

With new technologies in mobile computing, biotechnology and 3-D printing, it’s nearly impossible to keep up with the throngs of new innovation and still be able to forecast which companies are set to profit. Technology Profits Confidential is your one-stop shop for the companies of tomorrow’s technology… and how you can profit from them.

Login

Technology Profits Confidential Pro

LoginGet Access

Ray Blanco’s VIP Tech Advantage

LoginGet Access

Ray Blanco

Ray Blanco

Ray Blanco is the editor of Technology Profits Confidential as well as Breakthrough Technology Alert, FDA Profit Alert, and Technology Profits Daily. Ray has been with Seven Figure Publishing since 2010. In 2019, his closed positions in Technology Profits Confidential outperformed the S&P500 by 50%.

View More By Ray Blanco

Related Posts

Aveo Continues Expanding Beyond Kidney Cancer

Ray Blanco
By Ray BlancoPosted December 7, 2012

This company just announced news that the FDA accepted its application for tivozanib in renal cell carcinoma. Kidney cancer is a big market, and tivozanib has demonstrated superior performance to the competition in clinical trials. With approval, it could capture a significant part of that market.

TOPICS | , , , ,

ImmunoGen Taps Important Milestone, Plus Updates on Isis, Vertex, Sarepta and VirnetX

Ray Blanco
By Ray BlancoPosted March 1, 2013

It's been a great week for our portfolio. One of our reccomendations has achieved a first in its history. This week, the FDA approved T-DM1, a new breast cancer compound co-developed with Roche/Genentech. The compound, which belongs to a class of therapies known as antibody-drug conjugates (ADCs), hitches Roche's popular breast cancer antibody, trastuzumab (Herceptin), to a powerful cancer-killing compound using a molecular link, both of which were developed by ImmunoGen. It has been in clinical development for seven years.

TOPICS | , , , , ,

Start Your Own “Maker Revolution” For Less Than $1,000

Ray Blanco
By Ray BlancoPosted July 25, 2013
Lifetime Members Only

The future Chris Anderson envisions is about much more than using 3-D printers to make your own trinkets. It’s about opening the doors of entrepreneurship to anyone with a little imagination and an Internet connection. It’s not only the “next big thing.” We daresay it’s the only thing that can overcome the crushing burden of debt that still looms like a snow ledge over the next generation of Americans. “Any genuine recovery in America,” we wrote in 2011, “will be led by entrepreneurs who generate new ideas and create new jobs.”